ArticleEuropean child & adolescent psychiatry2022
First do no harm: use off-label antipsychotic medication in children and adolescents with great caution.
Article in European child & adolescent psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Risk of extrapyramidal symptoms associated with antipsychotic drugs in children and adolescents: a systematic review and meta-analysis of double-blind randomised placebo-controlled trials.Research square · 2026Article
- Neurological Adverse Effects of Antipsychotic Medication in Children and Young People.Paediatric drugs · 2026Review
- Off-label use of medications in psychiatry: the need and the caveats.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026Article
- Antipsychotic off-label use in the 21st century: An enduring public health concern.Dialogues in clinical neuroscience · 2025Review
- Offspring exposure to Crohn's disease during pregnancy and association with milder psychiatric regulatory disturbances in childhood.Acta obstetricia et gynecologica Scandinavica · 2025Article
- Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children.BMC pediatrics · 2025Article
- Antipsychotic prescribing: national findings of children and adolescents attending mental health services in Ireland.European child & adolescent psychiatry · 2024Article
- Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns.The mental health clinician · 2024Article
- Findings from an expert focus group on psychotropic medication deprescribing practices for children and youth with complex needs.Frontiers in child and adolescent psychiatry · 2024Article
- Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study.BMC public health · 2023Article
- Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study.Frontiers in pediatrics · 2023Article
- Trends in antipsychotic use among children and adolescents in Germany: a study using 2011-2020 nationwide outpatient claims data.Frontiers in psychiatry · 2023Article
- COVID-19 and Youth Psychopathological Distress in Umbria, Central Italy: A 2-Year Observational Study in a Real-World Setting.Frontiers in psychiatry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
35064827What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.